Evogene News, Evogene Quote, EVGN Quote

Evogene (NQ:EVGN) Delayed: 0.59 --0 (-0%)

Prev. Close

$0.59

Today 6M 1Y 5Y

Open

$0.58

52 Wk High

$9.32

52 Wk Low

$5.79

Day High

$0.60

Day Low

$0.57

P/E

N/A

EPS

$0.00

Volume

168,820

Friends, Peers and Foes (?): EVGIF, BESS, CMC, CWSFF, HEAT (more...)

ALERTS | RSS

Jun 11, 2026 04:06 PM Form 424B5 Evogene Ltd.
Jun 11, 2026 04:01 PM Form 6-K Evogene Ltd. For: Jun 11
Jun 9, 2026 07:00 AM Evogene to Present Its Pharma Division Achievements at the BIO International Convention
Jun 2, 2026 07:00 AM Evogene completes phase 1 trial of bacterial cancer treatment BMC128
Jun 2, 2026 07:00 AM Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica
May 28, 2026 05:57 PM EverGen Infrastructure Reports Q1 2026 Results
May 20, 2026 08:46 AM Form 424B3 Evogene Ltd.
May 20, 2026 07:03 AM Evogene (EVGN) Tops Q1 EPS by 26c
May 20, 2026 07:00 AM Form 6-K Evogene Ltd. For: May 20
May 20, 2026 07:00 AM Evogene Reports First Quarter 2026 Financial Results

Entities mentioned with EVGN

View All Entities